Comment on: Incidence of Adverse Psychiatric Events During the Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review

Jessica K Salwen-Deremer^{1

2}, Brittany C Speed¹

Affiliations

¹ Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
² Department of Medicine, Section of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

Editorial

Jessica K Salwen-Deremer et al. Crohns Colitis 360. 2019.

. 2019 Dec 19;2(1):otz051.

doi: 10.1093/crocol/otz051. eCollection 2020 Jan.

Jessica K Salwen-Deremer^{1

2}, Brittany C Speed¹

¹ Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
² Department of Medicine, Section of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

No abstract available

Comment on

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review.
Jain A, Marrie RA, Shafer LA, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Fisk JD, Bernstein CN. Jain A, et al. Crohns Colitis 360. 2020 Jan;2(1):otz053. doi: 10.1093/crocol/otz053. Epub 2019 Dec 19. Crohns Colitis 360. 2020. PMID: 32003760 Free PMC article.

1. Côté-Daigneault J, Bouin M, Lahaie R, et al. Biologics in inflammatory bowel disease: what are the data? United European Gastroenterol J. 2015;3:419–428. - PMC - PubMed
1. D’Haens G. Risks and benefits of biologic therapy for inflammatory bowel diseases. Gut. 2007;56:725–732. - PMC - PubMed
1. McLean LP, Cross RK. Adverse events in IBD: to stop or continue immune suppressant and biologic treatment. Expert Rev Gastroenterol Hepatol. 2014;8:223–240. - PMC - PubMed
1. Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:752–762. - PubMed
1. ClinicalTrials.gov Results Data Element Definitions for Interventional and Observational Studies.2018. (Accessed 11/09/2019, at https://prsinfo.clinicaltrials.gov/results_definitions.html#AdverseEvents.)